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Abstract
Background: Protein isoform generation, which may derive from alternative splicing, genetic polymorphism, and
posttranslational modification, is an essential source of achieving molecular diversity by eukaryotic cells. Previous
studies have shown that protein isoforms play critical roles in disease diagnosis, risk assessment, sub-typing,
prognosis, and treatment outcome predictions. Understanding the types, presence, and abundance of different
protein isoforms in different cellular and physiological conditions is a major task in functional proteomics, and may
pave ways to molecular biomarker discovery of human diseases. In tandem mass spectrometry (MS/MS) based
proteomics analysis, peptide peaks with exact matches to protein sequence records in the proteomics database
may be identified with mass spectrometry (MS) search software. However, due to limited annotation and poor
coverage of protein isoforms in proteomics databases, high throughput protein isoform identifications, particularly
those arising from alternative splicing and genetic polymorphism, have not been possible.
Results: Therefore, we present the PEPtidomics Protein Isoform Database (PEPPI, http://bio.informatics.iupui.edu/
peppi), a comprehensive database of computationally-synthesized human peptides that can identify protein
isoforms derived from either alternatively spliced mRNA transcripts or SNP variations. We collected genome, pre-
mRNA alternative splicing and SNP information from Ensembl. We synthesized in silico isoform transcripts that
cover all exons and theoretically possible junctions of exons and introns, as well as all their variations derived from
known SNPs. With three case studies, we further demonstrated that the database can help researchers discover
and characterize new protein isoform biomarkers from experimental proteomics data.
Conclusions: We developed a new tool for the proteomics community to characterize protein isoforms from MS-
based proteomics experiments. By cataloguing each peptide configurations in the PEPPI database, users can study
genetic variations and alternative splicing events at the proteome level. They can also batch-download peptide
sequences in FASTA format to search for MS/MS spectra derived from human samples. The database can help
generate novel hypotheses on molecular risk factors and molecular mechanisms of complex diseases, leading to
identification of potentially highly specific protein isoform biomarkers.
Background
Human cells benefit from elaborate mechanisms to
modify proteins, creating many protein variants (iso-
forms), both to increase the diversity of functions and to
regulate the activities of proteins. A protein isoform is
any of several different forms of the same protein.
Different forms of a protein may be produced from
related genes such as single-nucleotide polymorphisms
(SNPs) or may arise from the same gene by alternative
splicing or post-translational modifications (PTM).
Alternative splicing and SNPs expands the number of
messenger RNAs to about 88,000 mRNA variants during
transcription of these genes. About 8% of these protein
isoforms are generated from mRNA transcripts affected
by alternative splicing or SNPs, whereas over 90% of
protein isoforms are created through post-translational
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a protein [1]. Recent studies have shown that the identi-
fication, analysis and characterization of these individual
protein isoforms (Alternative Splicing, SNPs and PTMs)
could improve understanding of diseases improve dis-
ease diagnosis or interventions [2-11].
Recent advances in clinical proteomics technology,
particularly liquid chromatography-coupled tandem
mass spectrometry (LC-MS/MS), have enabled biomedi-
cal researchers to characterize thousands of proteins in
parallel in biological samples[12]. Identifying disease-
related protein isoforms using tandem mass spectrome-
try, therefore, can provide hope for improving both the
sensitivity and the specificity of candidate disease bio-
markers, because proteomics identification, instead of
quantification, of the same set of protein isoforms is
often sufficient to distinguish between disease samples
and controls.
However, identifying protein isoforms using current
MS proteomics search databases and software tools has
been challenging, primarily because of the smaller size
of known or common alternatively spliced protein iso-
forms relative to several orders of magnitude larger size
of MS search databases, which makes exhaustive novel
peptide identification computationally inefficient for
routine proteomics studies. Up to 80% of all MS spectra
peaks in a typical proteomics experiment may remain
uncharacterized when searched against a standard MS
database with little protein isoform information. Such
standard MS search databases include: the IPI database
[13], the NCBI-nr database, and the UniProt knowledge
base [14]. These databases integrate more than a dozen
public protein and DNA sequence databases into a non-
r e d u n d a n tl i s to fb o t hk n o w na n dp r e d i c t e dp r o t e i n
sequences, with only publicly known splice variant tran-
scripts represented. MS search software such as
SEQUEST [15], Mascot [16], X!Tandem [17], and
OMSSA [18]. may further allow customized identifica-
tion of limited types of PTM-derived peptides and pro-
teins. However, these protein sequence databases do not
contain information about alternatively spliced tran-
scripts or theoretically possible “mis-spliced” protein iso-
forms; nor do they contain peptide variants arising from
SNPs that result in amino acid changes. Therefore, they
are ill-suited for comprehensive protein isoform identifi-
cation purposes.
Although there are several publicly available alterna-
tive splicing mRNA transcript databases and SNP data-
bases including ASTD [19], EID [20,21], ASPicDB [22],
ECgene [23], MutDB [24,25], and dbSNP [26], none of
these databases can be readily used for identification of
novel peptides derived from uncharacterized protein iso-
forms. Since predictions of gene splicing patterns in all
the methods are based on alignments of transcript data
(mostly expressed sequence tags, ESTs) to a genomic
sequence, some limitations exist in all these methods
mostly due to the sequence errors frequently occurring
in ESTs and to the repetitive structure of the genome
sequence. Moreover, all the databases mentioned con-
tain a rather small set of alternatively spliced peptides
because they are either manually curated or literature-
based data sets, as well as poor annotation of splice
events, which are inadequate for the identification of
alternatively spliced protein isoforms. To explore the
huge solution space of all possible alternatively spliced
combination of exons and potentially coding introns,
one must generate virtual peptides exhaustively so that
uncharacterized MS spectra can be searched against
them. In addition, the database of virtual peptides
should be expanded to accommodate the amino acid
alterations introduced by each SNP.
In this paper, we describe the development of a Pepti-
deomics Database of Protein Isoforms (PEPPI), which
consists of systematically generated virtual peptides that
cover alternative splicing events and known SNP varia-
tions, for identifying protein isoforms in large-scale pro-
teomics results. In the PEPPI database, we introduce a
peptidomics approach to integrating genome, transcrip-
tome, proteome and SNP information for human proteo-
mics studies. The database contains a comprehensive set
of peptides derived from all known annotated human
genes in the Genome Reference Consortium Human gen-
ome build 37 by generating alternative splicing events
and incorporating non-synonymous SNPs. It is the first
comprehensive database that can be used to characterize
novel protein isoforms derived from alternative splicing
and SNP variations in MS spectra. The database has a
web user interface that allows its users to query a gene/
protein and compare all its above-mentioned types of
protein isoforms and associated virtual peptides online.
Results
Database content
Drawn from Ensembl’s genomic data [27], the PEPPI
database contains a comprehensive set of peptides
derived from all known human protein-coding genes
and was constructed by generating both annotated and
hypothetical alternative splicing events and incorporat-
ing non-synonymous SNPs. In addition to representing
an in-frame peptide for each exonic region (EXON_KB)
of human proteins, four types of PEPPI splice junctions
are also captured for all possible combinations of
each coding sequence of gene: annotated exon-exon
junctions (E_E_KB type), hypothetical exon-exon junc-
tions (E_E_TH type), hypothetical exon-intron junctions
(E_I_TH type), and hypothetical intron-exon junctions
(I_E_TH type). An exonic region or a splice junction is
defined as a peptide region. For each peptide region, we
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known non-synonymous SNP. By cataloguing each pep-
tide configurations in the PEPPI database, users can study
alternative splicing events such as exon skipping, alterna-
tive donor site, alternative accepter site, and intron reten-
tion at the proteome level. They can also batch-download
the peptide annotation and sequences in FASTA format
for MS data searching. The current PEPPI database
includes human data only. As of April 2010, it is com-
prised of 7,848,236 PEPPI peptide entries derived from
23,491 protein-coding genes and 66,384 proteins, incor-
porating 150,054 non-synonymous SNPs (Table 1).
A peptide-protein mapping is also captured for compar-
ing the MS search results derived with the PEPPI and con-
ventional protein sequence databases. In total 613,591
peptides are mapped to 66,384 IPI [13] proteins (Table 1).
General online features
In Figure 1, we show the user interfaces of the web-
based online version of the PEPPI database. It allows
searching by Ensembl Gene ID, gene symbol, UniProt
ID, IPI AC, peptide sequence, PEPPI Peptide Region ID
and PEPPI Peptide ID. With the cross-links users can
easily link to Ensembl [27], IPI [13], UniProt [28],
HAPPI [29] and HPD [30] and get access to much more
detailed information about genes, proteins, protein-pro-
tein interactions and human pathways. The peptide
annotations and sequences are freely available for batch-
download in FASTA format on the download page.
Case studies
We show three case studies of increasing complexity
and biological significance to demonstrate that the data-
base can help researchers discover and characterize new
protein isoform biomarkers from experimental proteo-
mics data.
Case study 1: browsing PEPPI peptides and relating
information based on a query gene
For users who would like to review all the peptide
regions and peptides within a gene of interest, we pro-
vide the standard gene search procedure. In this case
study we show how to browse the PEPPI peptide
regions, PEPPI peptides and related information within
gene PRH1. Users will start from the Search Home (Fig-
u r e1 A ) ,g ot h r o u g ht h eG e n eV i e w( F i g u r e1 B ) ,R e g i o n
View (Figure 1C), and finally navigate to the Peptide
View (Figure 1D).
By searching with gene PRH1 in the standard query
box provided at the PEPPI database home page, users
can retrieve all peptide regions corresponding to this
gene (Figure 2). In the Gene View, the PEPPI database
visualizes all the peptide regions that can be mapped to
this gene. The “Location” section shows this gene is
located on chromosome 12, from 11,033,560 bp to
11,036,883 bp. Links to Ensembl are provided on the
gene ID and location. A scale of chromosome coordi-
nate is provided on the top and bottom of the visualiza-
tion. The arrow on the chromosome coordinate scale
shows this gene is located on the reverse strand, so the
5’ end of the gene should be the right end. Peptide
regions are displayed in five categories, including
EXON_KB, E_E_KB, E_I_TH, I_E_TH and E_E_TH.
The color of the region indicates the protein translation
open reading frame (ORF) of the corresponding cDNA.
By clicking on the peptide region REG005324254, the
browser will be re-directed to the Region View.
The Region View (Figure 3) displays detailed informa-
tion of the peptide region and the peptide sequences
within this region. In the “Peptide Region Overview”
section, the exon coordinate is the chromosome coordi-
nate of the source exon, and the segment coordinate is
the coordinate of the flanking sequence beside the splice
site. The peptide without SNP is displayed on the top of
the “cDNA/Peptide Sequence” section, and the peptides
with SNPs are displayed below. In the sequences, black
and blue are used to color different exons/introns. An
amino acid residue overlapping a splice site is colored in
red. SNPs are highlighted by green and light cyan. By
clicking on the highlighted SNPs, the SNP ID will be
shown along with the nucleotide change and amino acid
change. A link to the corresponding page in dbSNP is
also provided. By clicking on a PEPPI peptide ID, e.g.,
Table 1 Database Content Statistics
Region Type Regions / Peptides without SNP Peptides with SNP All Peptides of the Region Type
EXON_KB 264,599 140,777 405,376
E_E_KB 259,329 146,016 405,345
E_I_TH 400,571 126,678 527,249
I_E_TH 108,754 41,977 150,731
E_E_TH 4,291,289 2,068,246 6,359,535
Total 5,324,542 2,523,694 7,848,236
Mapped Genes: 23,516
Mapped Proteins: 66,384
Non-synonymous SNP: 150,054
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Page 3 of 13“PEP007847820”, the browser will be navigated to the
Peptide View.
In the Peptide View (Figure 4), detailed information of
the peptide region and a peptide-protein mapping is
shown in the “Peptide Region Overview” section. The
cDNA and peptide sequence is displayed in the same
pattern as the Region View. The “Protein Mapping” sec-
tion lists the proteins mapped to the current peptide.
The result shows that IPI00847261 is the only protein
mapped to the peptide PEP007847820. The annotation
on IPI states that IPI00847261 is one of the protein pro-
ducts of PRH1. Since the peptide PEP007847820 con-
tains a mutant non-synonymous SNP allele, we can
infer that the mapped protein IPI00847261 is not the
wild-type.
Case study 2: identifying genomic origins and alternative
splicing events from peptides detected in MS experiments
For users, especially MS proteomics scientists, who want
to start the query from a peptide sequence or a protein,
we provided a peptide sequence search function (Figure
1F) and the Protein View (Figure 1E). In this case study
we demonstrate that the PEPPI database can help iden-
tify the genomic origins of peptides detected from MS
data, and can help characterize the alternative splicing
events related to these peptides.
The MS peptides can be derived from Healthy Human
Individual’s Integrated Plasma Proteome Database (HIP-
2) [31] by inputting its protein ID. For this example, by
entering “IPI00023636” as the query, a mapping table
with several MS peptides identified by the MS data ana-
lysis program will be returned (Figure 5A). To identify
the genomic region that encodes a specific peptide
sequence, we can search the peptide sequence on the
PEPPI database’s search home.
As shown in Figure 5B and 5C, peptide 1 is mapped
to “PEP000841715”, which is an E_E_KB peptide, and
peptide 2 is mapped to “PEP000841692” which is an
EXON_KB peptide. This indicates peptide 1 is coded by
Figure 1 Web Interface Structure (A) Search Home: main search page allowing five types of query string: Ensembl gene ID, IPI protein
accession number, peptide sequence, PEPPI region ID and peptide ID. (B) Gene View: search result page visualizing peptide regions within a
gene. (C) Region View: search result page displaying peptides within a peptide region. (D) Peptide View: PEPPI peptide information page. (E)
Protein View: search result page of PEPPI peptides mapped to an IPI protein. (F) Sequence Search: search result page of PEPPI peptides mapped
to a query peptide sequence.
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gle exon.
To study the related alternative splicing events, we
then compared the number of proteins which can be
mapped to these peptides. By clicking on the peptide
ID, we can get access to the proteins mapped to each
peptide. We found 4 proteins mapped to peptide 1, and
5 proteins mapped to peptide 2. Interestingly, only one
protein (IPI00745806) was differentially mapped. By
looking up the protein information in IPI, we found that
the proteins involved are five different alternatively
spliced isoforms of MP2K7_HUMAN, and IPI00745806
is the third isoform. Therefore, it is likely that only a
specific alternative splicing event that takes place is
annotated and can be mapped onto the protein
sequence IPI00745806.
To verify our suspicion on the existence of the
alternative splicing event, we compared the protein-
peptide mapping of the wild-type and the third iso-
form of MP2K7_HUMAN. In the wild-type
MP2K7_HUMAN (Figure 5D), “PEP000841715” con-
tains the splice junction of two exons (PEP000841690
and PEP000841692), and peptide 1 just crosses the
splice site. Nevertheless, in the MP2K7_HUMAN iso-
form 3 (Figure 5E), we found a unique cassette exon
(PEP000841691) spliced between the two exons,
which hampered the coding of sub-sequence map-
pable to peptide 1. Meanwhile, peptide 2 is only
mapped to a single exon (PEP000841692), which
exists in all five proteins and unaffected by any splice
events. Thus we have confirmed the suspicion that a
cassette exon event caused the protein mapping dif-
ference between two MS peptides, and have shown
the PEPPI database’s ability to help infer alternative
splicing events from peptides detected from MS
experiments.
Figure 2 Gene View (A) Gene scale. Shows the user the chromosome coordinates and strand of the gene. With the gene scale, users can read
the approximate position of the peptide regions. (B) Peptide regions. Shows the user which five types of peptide regions within current given
gene that the peptide belong to. The coloring of the peptide regions indicates the ORF (Red: 0, Green: 1, Blue: 2). The solid bars indicate exons,
and the blank bars indicate introns. The curve between two exons means the exons are spliced with each other.
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Page 5 of 13Figure 3 Region View (A) The different colors of the cDNA and peptide sequences indicate two different exons, or an exon and an intron. The
amino acid letter colored in red overlaps with the splice site. (B) Green and light cyan backgrounds are used to indicate SNP in cDNA and
peptide sequences. (C) By clicking on a SNP in sequence, users can see the details of the SNP. A link to the dbSNP database is provided.
Figure 4 Peptide View (A) The cDNA and peptide sequences that the current PEPPI peptide is mapped to. Same color theme is used in the
region view. By clicking on SNP in sequence, users can access detailed information of the SNP. (B) In the protein mapping list, the view displays
all the proteins mapped to the current PEPPI peptide. The peptide sequence is highlighted from within the protein sequence.
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Human fetal liver can evolve into a major site of
embryonic hematopoiesis; therefore, protein profiling
may help researchers understand how the interaction
between hepatic and hematopoietic systems and the
migration of the hematopoietic system during mamma-
lian development take place. We collected four human
fetal liver cytoplasm proteome data sets from the
human fetal liver project (http://hlpic.hupo.org.cn
/dblep). SDS-PAGE with different cross-linking percen-
tages 15%, 10%, and 7.5% was used for protein separa-
tion to obtain a full representation of proteins ranging
from 5 kDa to more than 300 kDa. After these gels
were stained with Colloidal Coomassie Blue R250 and
t h eg e ll a n e sw e r em a n u a l l ye x c i s e df r o ml o a d i n gp o s i -
tion to the bottom of the gel, the extracted peptide mix-
tures were loaded onto nanoscale LC-ESI-Q-TOF MS or
micro-LC-ion trap MS systems for protein identification
[32].
In order to show that the PEPPI database can be used
to identify additional novel peptide isoforms than the
traditional protein database, we downloaded the protein
database IPI and created three datasets using the PEPPI
database: 1) annotated exonic peptides and exon-exon
combinations without SNP (PEPPI_KB), 2) all PEPPI
peptides without SNP (PEPPI_without_SNP), and 3) all
PEPPI peptides including peptides with SNP (PEPPI_-
with_SNP). PEPPI_KB consists of peptides of both the
EXON_KB and E_E_KB region types without additional
SNP permutations; PEPPI_without_SNP consists of pep-
tides of the EXON_KB, E_E_KB, E_I_TH, I_E_TH, and
E_E_TH region types without additional SNP permuta-
tions; PEPPI_with_SNP consists of peptides of all types,
with or without SNPs, in the PEPPI database. We also
created four corresponding inverse sequence datasets to
evaluate the false discovery rate with a target-decoy
search strategy [33]. The four peak list files of human
fetal liver from LC-ESI-Q-TOF MS or micro-LC-ion
Figure 5 Identifying The Genomic Origin of MS Detected Peptides and The Relating Alternative Splicing Event (A) The HIP-2 search
result page of protein IPI00023636, displaying the evidence peptides detected in MS experiments. (B) The PEPPI sequence search result page of
peptide 1, indicating the query peptide is produced from an exon-exon combination region. The corresponding PEPPI peptide can be mapped
to 4 proteins. (C) The sequence search result page of peptide 2, indicating the peptide comes from an exon, and can be mapped to 5 proteins.
(D) The search result of the wild-type MP2K7_HUMAN, showing the regions mapped by the peptides. Peptide 1 crosses the splice site of two
exons (PEP000841690 and PEP000841692). Peptide 2 is produced from a single exon, PEP000841692. (E) The search result of the 3
rd isoform of
MP2K7_HUMAN, the protein that is mapped to the peptide 2 but not mapped to peptide 1. That is because the insertion of a cassette exon
(PEP000841691) changed the sequence of the protein.
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the four databases and their four inverse databases in
order to compare the results among them.
OMSSA reports hits ranked by E-value. An E-value
for a hit is a score that is the expected number of ran-
d o mh i t sf r o mas e a r c hl i b r a r yt oag i v e ns p e c t r u m ,
such that the random hits have an equal or better score
than the hit. For example, a hit with an E-value of 1.0
implies that one hit with a score equal to or better than
the hit being scored would be expected at random from
a sequence library search [18]. The search results with
OMSSA can vary substantially with differing search
parameters, sequence libraries, and samples [33]. There-
fore, we adopted the MS/MS false discovery rate (FDR)
instead of E-value as scoring criterion for evaluating the
four databases, and this method is based on commonly
used scoring methodologies and the target-decoy search
strategy [33]. All other OMSSA search parameters [18]
for the four databases are the same. To increase identifi-
cation accuracy, only peptides/proteins with at least two
hits of different samples was recognized as true pep-
tides/proteins.
A comparison of search results against four MS data-
bases, i.e., IPI, PEPPI_KB, PEPPI_without_SNP, and
PEPPI_with_SNP, is shown in Table 2. Results are
shown only at a commonly used 1% MS/MS FDR for
each database. Compared to the traditional IPI database,
the elapsed time for PEPPI_KB decreased although the
dataset size increased by two and a half times. And with
t h ei n c r e a s eo fs i z e s ,t h ee l a p sed time increases signifi-
cantly linearly from PEPPI_KB to PEPPI_without_SNP
to PEPPI_with_SNP (Intercept = 8.17021, slope=0.04738
, and adjusted R
2= 0.9975).
Under the criteria of MS/MS FDR 0.01, the target
MS/MS hits markedly increases with the increase of
database size, and target peptide hits, target protein hits,
and target PEPPI hits all increase while the correspond-
ing FDRs remained approximate. The overlap of genes
identified by each database is shown graphically by
Venn diagram in Figure 6. The results show that the
PEPPI database can be used to identify more peptides/
proteins under the same false positive rate than the tra-
ditional IPI database.
From the four human fetal liver MS data sets, we
identified 63 peptides which mapped to 74 PEPPI pep-
tides and 9 SNP events using PEPPI_with_SNP (See
additional file 1). Among the 74 PEPPI peptides, 55
EXON_KB type peptides were also annotated previously
in IPI, and 19 peptides were novel peptides uniquely
identified with the PEPPI database (13 E_E_KB type
peptides, 2 E_E_TH type peptides, 1 I_E_TH type pep-
tide, and 3 E_I_TH type peptides).
The peptide hit matrix shows the number of PEPPI
peptides mapped to the peptides detected from the sam-
ples, and the number of samples (N) in which the pep-
tide is detected (See additional file 2).
Discussion and perspectives
We created a comprehensive PEPPI database of both
annotated and hypothetical peptides representing
human protein isoforms for MS analysis. The PEPPI
database made it possible for high-throughput identifica-
tion of gene variations, exon expression, and alternative
splicing events at the proteome level. We also con-
structed a web-server for searching and visualizing the
peptides. With the user-friendly interface and powerful
search functions, users can easily study the alternative
splicing events and gene variations related to any gene,
protein, or peptide sequence of interest.
A comparison between the PEPPI database and con-
ventional MS methods is shown in Table 3. An MS
approach with the PEPPI database uses the same
Table 2 Summary of Search Results When MS/MS FDR ≤ 0.01
IPI PEPPI_KB PEPPI_without_SNP PEPPI_with_SNP
Size (M) 47 115.2 1181.1 1769.7
Elapsed Time(h:mm:ss) 0:11:05 0:10:39 1:02:32 1:33:04
MS
2 FDR 0.01000 0.00992 0.00996 0.00999
Target MS
2 hits 22685 21473 68137 116363
Decoy MS
2 hits 114 107 341 584
Peptide FDR 0.01575 0.01527 0.01242 0.01571
Target peptide hits 125 129 159 188
Decoy peptide hits 2 2 2 3
Protein/gene FDR 0.02797 0.02778 0.02439 0.02339
Target protein/gene hits 368/141 142 162 169
Decoy protein/gene hits 5/2 2 2 2
PEPPI FDR 0.01376 0.01283 0.01376
Target PEPPI hits 433 1549 2886
Decoy PEPPI hits 3 10 20
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tional MS approach. To use the PEPPI database, users
just need to set the PEPPI database or a subset of the
PEPPI database as the user defined sequence database in
the MS search software. With the PEPPI database, users
can gain information on the expression of exons, alter-
native splicing events, SNPs, and protein existence from
the proteome, while the conventional MS approach can
only derive the protein existence information. Users can
opt to use different subsets of the PEPPI database for
different study purposes. The computational cost of
adopting the PEPPI database approach over a conven-
tional approach is kept low, due to the use of computing
cycles without human intervention.
Since the database incorporated a large number of
hypothetical peptides, it is possible that the search result
contains false positives due to the noise. To solve this
problem, we will design an optimized routine for MS
data analysis. For example, users may analyze several
samples at one time, and only keep the peptides
detected in more than one sample. On the other hand, a
recently published article [34] reported tissue dependent
splicing patterns, which make it possible to generate tis-
sue specific PEPPI peptides and reduce the chance of
incorporating false positives.
In the future, we plan to enhance the user interface of
the web application such as replacing the static down-
load page with an interactive batch-download interface,
where users can specify the peptide type, gene IDs and
protein IDs. We also plan to improve the performance
of peptide sequence search with parallel computing and
a more powerful database server.
Methods
Genome data source
The PEPPI peptides were generated from the human
genome. The source genome data was downloaded from
Ensembl Version 55 [27] with BioMart[35]. As shown in
Figure 7A, four tables, including Un-Translated Region
(UTR), Gene Sequence, Gene-Protein Mapping and
Gene Structure, were pulled from the Ensembl Homo
sapiens Genes Dataset. The UTR table describes the
coordinates for all transcript UTRs. The Gene Sequence
table contains chromosome coordinates and sequences
in FASTA format. The Gene Structure table contains
the exon annotation information, including Exon ID,
Gene ID, Transcript ID, as well as the genome coordi-
nate and translation phase of the exons. The SNP table
was derived from the Ensembl Homo sapiens Variation
Dataset, and contains the SNP’s chromosome coordinate
Figure 6 Overlap of Peptides/Genes Identified by Four Search Databases. (A) Peptides identified from two or more samples. (B) Proteins
identified from two or more samples.
Table 3 Comparison with Conventional MS Methods
MS with PEPPI Conventional MS Methods
Sample Same as right Ordinary proteome samples
Spectrum Same as right Ordinary MS equipments
Software Same as right SEQUEST, Mascot, OMSSA etc.
Sequence Database PEPPI or subset of PEPPI Conventional protein sequence databases (IPI, UniProtKB, e.g.)
Detection Ability 1. Exonic region
2. Exon-Exon combinations (annotated transcripts)
3. Exon-Intron combinations
4. Intron-Exon combinations
5. Hypothetical Exon-Exon combinations
6. SNP peptides
Only proteins
Configuration User configurable Pre-defined by database producer
Cost Same as right Not very expensive
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44,285 genes and 16,489,577 SNPs.
Data pre-processing
A data pre-processing procedure (Figure 7B) was imple-
mented to remove non-coding genes and SNPs which
are not in exonic regions.
F i r s t l yw ei m p o r t e da l lt h es o u r c et a b l e si n t oa
SQLite3 database with the SQLite3 command-line inter-
face, and then we used SQL statements to remove non-
coding genes. The Gene-Protein Mapping was utilized
as a filter, and genes not mapped to proteins were
considered as non-coding genes. The Coding Gene
Sequence and Coding Gene Structure table was derived
after filtering, and 21,351 protein-coding genes were
captured.
Then we compiled a C program with the SQLite3
library to extract the annotated transcription informa-
tion from the Coding Gene Structure table, and pro-
duced two tables. The Exon Knowledgebase table
describes all the protein-coding exons, and the Exon
Comb Knowledgebase table describes all the exon-exon
combinations found in the annotated transcripts. Then
the SNP table was searched against the Exon
Figure 7 Data Generation Process. The whole data generation process was divided into three steps: (A) deriving the genome data from
Ensembl; (B) pre-processing of the data to select protein-coding genes and SNPs within coding exons; and (C) generation of peptide regions
and PEPPI peptides. The result datasets are colored in red.
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annotated coding exons were retrieved for peptide
generation.
Peptide region generation
We compiled a pipeline program with C and the
SQLite3 library to generate peptide regions (Figure 7C).
The program first generated the wild-type cDNA
sequences of the peptide region, and then translated the
cDNA sequences into peptides. The derived peptides
were estimated by the program according to a set of
protocols, and un-qualified peptides and the corre-
sponding region were discarded. Different cDNA gen-
eration procedures and peptide estimation protocols
were implemented on different types of peptide regions
(Table 4).
For the EXON_KB type, the chromosome coordinate
of the exons were derived directly from the Exon
Knowledgebase table, and the whole length of the exon
cDNA sequence was captured from the gene sequence.
Then the exon’s cDNA sequences were translated into
peptides according to the annotated ORF. In the peptide
estimation process, if a stop codon existed anywhere
except the end of the peptide, the corresponding region
was considered invalid and was discarded.
Similar to the EXON_KB type, the chromosome coor-
dinates of the two exons in the E_E_KB type were
derived directly from the Exon Comb Knowledgebase
table. Then the derived cDNA sequences were translated
into peptides according to the annotated ORF of the
exon on the 5’ end. The same peptide estimation proto-
col used with the EXON_KB type was applied to the
E_E_KB type.
For the E_I_TH and I_E_TH type, the program
derived the chromosome coordinates of exons from the
Exon Knowledgebase table and spliced them with the
adjacent introns. The cDNA flanking sequence on both
side of the splice site was limited to 120 nucleotides. If
Table 4 Data Generation Protocols
cDNA Sequence Length Open Reading Frame (ORF) Stop Codon Toleration
EXON_KB Whole Length Annotated ORF Only Not Tolerated
E_E_KB ≤ 240 bp Annotated ORF Only Not Tolerated
E_I_TH ≤ 240 bp All 3 ORFs In 3’ end segment
I_E_TH ≤ 240 bp All 3 ORFs Not Tolerated
E_E_TH ≤ 240 bp All 3 ORFs In 3’ end segment
We limited the lengths of the combination transcripts to 240 bp, with a flanking sequence of 120 bp on each side of the splice site.
Figure 8 The UML of Database Backend The datasets derived by the data generation pipeline are colored in red, and the datasets derived
from other databases are colored in black.
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gram will pull out the actual sequence. This limit was
set according to the longest peptide in the HIP-2 data-
base [31], which had a length of 80 amino acids and
corresponded to 240 nucleotides in the cDNA sequence.
This represents the length of the longest peptide that
can be identified from an MS experiment. In this way
we made sure that any MS identified peptide that
crosses the splice site can be captured by the PEPPI
database. In the peptide estimation process, a stop
codon is tolerated in the intron of E_I_TH, but not tol-
erated anywhere expect the 3’ end in I_E_TH.
When producing the E_E_TH type of peptide regions,
all possible exon-exon combinations were generated and
searched against the Exon Comb table. Any combina-
tions that cannot be found in the Exon Comb table
were captured as an E_E_TH type candidate. Then each
E_E_TH type cDNA was translated in all 3 ORFs, and if
a stop codon was found in the 5’ end exon, the peptide
was discarded. Note if more than one E_E_TH peptide
derived from the 3 ORFs were considered valid, then a
peptide region was created for each ORF.
PEPPI peptide generation
After the generation of peptide region, PEPPI peptides
were produced by inserting non-synonymous SNPs into
the wild-type peptide of the corresponding region (Fig-
ure 7C). All the non-synonymous SNPs within a peptide
region were first captured in a list, and then inserted
into the wild-type cDNA according to their chromo-
some coordinates. Each cDNA sequence with SNP was
then translated into peptides. The peptides were then
estimated according to the peptide estimation protocol
of its own region type, and invalid ones were discarded.
During peptide generation, a table of Peptide-SNP Map-
pings was also generated. The wild type peptides were
also deposited in the PEPPI Peptide table.
Online PEPPI server design
The online version of PEPPI database is a typical 3-tier
web application, with a MySQL database at the backend
database service layer, Apache/PHP server scripts to the
middleware application web server layer, and CSS driven
web pages presented on the browser. The Javascript
library uuCanvas (http://uupaa-js-spinoff.googlecode.
com/svn/trunk/uuCanvas.js/) is used to render the real-
time data visualizations in the gene view and the protein
view.
The result tables derived from the data generation
step were imported into the MySQL database (Figure 8).
The chromosome coordinate information was deposited
in the Peptide Region table, and the sequence informa-
tion was deposited in the PEPPI Peptide table. The ID
mapping tables for genes and proteins enable users to
query the database with different IDs.
Additional material
Additional File 1: 63 Peptides Identified by PEPPI
Additional File 2: Peptide Hit MatrixN: number of samples in which
the peptide is detected The 2nd to 9th columns are 8 human fetal liver
samples marked by Pride accession numbers. The digits in the 8 columns
represent the numbers of PEPPI peptides mapped to the peptides
detected from the samples.
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